AIDS at a

Crossroads

in Canada

A Call For Urgent Action

HIV/AIDS Control is off Track in Canada and Globally in 2025

.01

PHAC reported earlier this year that Canada has seen a 35% increase in HIV new infections between 2022 and 2023. Since then, nearly all regions in Canada are reporting further increases in HIV new infections. Saskatchewan and Manitoba are particularly impacted, as are minorities, priority populations and specially First Nations across the country.

.02

Antiretroviral Therapy (ART) mediated Treatment as Prevention (TasP), a made-in-Canada strategy, combined with Pre-Exposure Prophylaxis (PrEP), can “End HIV/AIDS as an Epidemic” in Canada and globally by 2030. This saves lives, prevents infections, protect societies and saves money.

.03

The Targets to achieve the “End HIV/AIDS as an Epidemic” in Canada and globally by 2030, are also a Canadian innovation, endorsed by the UN and Canada in 2015, and ratified in 2020. These remain in place until 2030.

.04

Recent cuts to domestic and international health programs, primarily (but not exclusively) by the US, have seriously compromised efforts to meet the “End HIV/AIDS as an Epidemic” here and globally by 2030. Indeed, we are already seeing substantial increases in HIV infection among immigrants and refugees.

Fortunately, we have a plan:

Redouble efforts to meet the 95-95-95 Target to achieve the“End HIV/AIDS as an Epidemic” in Canada by 2030

2
Enhance phylogenetic monitoring of clusters nationally
4
Harmonize risk reduction policies across the country
6
Enhance social/medical supports for priority populations
1
Fully fund HAART and PrEP within Pharmacare
3
Set up a centralized frequent reporting at PHAC
5
Address the overcriminalization of HIV transmission
7
Increase the support of the Global Fund (Lead by example)
1
Fully fund HAART and PrEP within Pharmacare
2
Enhance phylogenetic monitoring of clusters nationally
3
Set up a centralized frequent reporting at PHAC
4
Harmonize risk reduction policies across the country
5
Address the overcriminalization of HIV transmission
6
Enhance social/medical supports for priority populations
7
Increase the support of the Global Fund (Lead by example)
Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

Start typing and press enter to search